Home › Core › ISCC-IDs › 28CrA25zuksRC

View ISCC-ID

Core Data

28CrA25zuksRC
ISCC-ID - digital asset identifier
CCLTvPG3DA9rC-CTYpxw6c7nNWC-CDfgZbKkbjRve-CRF8vNvTXphEz
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

gene and cellreplacement therapy in the treatment of type 1 diabetes how high must the standards be set

Ledger Reference

coblo
Source Ledger/Blockchain
12408126
N-th ISCC Decleration on source ledger
508581e7603fa122ac44508a37b5ca790153a621f3d9a2f2a0c86fdc919e0182
Hash of block that includes the ISCC-DECLARATION
a8e523aa854bad6f5e51f913a4fc5daf11a943414277647d278d9a23d0e20d1e
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Gene and Cell-Replacement Therapy in the Treatment of Type 1 Diabetes: How High Must the Standards Be Set?", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "P. A. Halban", "@type": "Person"}, {"name": "S. E. Kahn", "@type": "Person"}, {"name": "A. Lernmark", "@type": "Person"}, {"name": "C. J. Rhodes", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://diabetes.diabetesjournals.org/content/50/10/2181.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Diabetes Association", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.2337/diabetes.50.10.2181", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLTvPG3DA9rC-CTYpxw6c7nNWC-CDfgZbKkbjRve-CRF8vNvTXphEz", "propertyID": "ISCC"}], "datePublished": "2001-10-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close